OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
October 03, 2022
BFS technology can help maintain sterility during the biologics manufacturing process.
Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.
October 02, 2022
Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.
A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
FDA backs joint reviews, common research policies, and modern production methods around the world.
ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.
The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.
L.B. Bohle’s QbCon 1 is intended to meet all quality requirements for long granulation processing time.
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
